z-logo
open-access-imgOpen Access
Role of daratumumab in relapsed or refractory multiple myeloma patient: A meta-analysis and literature to review
Author(s) -
Abubakar Tauseef,
Maryam Zafar,
Peter T. Silberstein,
Joseph Nahas,
Thomas Frederickson,
Faith Abodunrin,
Anum Abbas,
Wafa Arshad,
Noman Lateef,
Hussain I Rangoonwala,
Sara Albagoush,
Mohsin Mirza
Publication year - 2022
Publication title -
journal of family medicine and primary care
Language(s) - English
Resource type - Journals
eISSN - 2278-7135
pISSN - 2249-4863
DOI - 10.4103/jfmpc.jfmpc_1987_21
Subject(s) - daratumumab , medicine , multiple myeloma , adverse effect , meta analysis , oncology , clinical trial , bortezomib

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom